Genetic strategies to elucidate the roles of matrix metalloproteinases in atherosclerotic plaque growth and stability.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation Research

• Publication date

  2005-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.RES.0000193565.23357.C0PMID 16284186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haplotype Effect of the Matrix Metalloproteinase-1 Gene on Risk of Myocardial Infarction

  2005cited by this paper
• Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries

  2005cited by this paper
• Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.

  2005cited by this paper
• Proinflammatory Genetic Profiles in Subjects With History of Ischemic Stroke

  2004cited by this paper
• Clinical and Biochemical Results of the Metalloproteinase Inhibition with Subantimicrobial Doses of Doxycycline to Prevent Acute Coronary Syndromes (MIDAS) Pilot Trial

  2004cited by this paper
• Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors.

  2004cited by this paper
• Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population

  2004cited by this paper
• Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth

  2004cited by this paper
• Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors.

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Structure , Function , and Biochemistry

  2003cited by this paper
• Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease.

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease

  2003cited by this paper
• Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction.

  2003cited by this paper
• Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Promoter Polymorphisms Are Associated With Carotid Artery Stenosis

  2002cited by this paper
• Persistence of Atherosclerotic Plaque but Reduced Aneurysm Formation in Mice With Stromelysin-1 (MMP-3) Gene Inactivation

  2001cited by this paper
• Coronary Artery Complicated Lesion Area Is Related to Functional Polymorphism of Matrix Metalloproteinase 9 Gene: An Autopsy Study

  2001cited by this paper
• ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis.

  2001cited by this paper
• Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction.

  1999cited by this paper
• Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

  1999cited by this paper
• Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques.

  1999cited by this paper

• Prediction of Targets and Mechanisms of Top Ten Core “Food–Medicine Homologous Traditional Chinese Medicines” in Delaying Vascular Aging: An Integrative Computational Study

  2026cites this paper
• Association of inflammation, destruction and angiogenesis genes polymorphism with serum levels of matrix metalloproteinases 3 and 9 in patients with coronary atherosclerosis

  2022cites this paper
• The Benefits of Omega-3 Fats for Stabilizing and Remodeling Atherosclerosis.

  2020cites this paper
• Anti-Inflammatory Actions of Soluble Ninjurin-1 Ameliorate Atherosclerosis

  2020cites this paper
• An MMP/TIMP ratio scoring system as a potential predictive marker of diabetic foot ulcer healing.

  2018cites this paper
• Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges.

  2017cites this paper
• Role of Matrix Metalloproteinases in the Development and Progression of Atherosclerosis

  2017cites this paper
• Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective

  2017cites this paper
• [Association of Some Homozygous Genotypes of Genes Regulating Inflammation, Destruction and Angiogenesis With Laboratory Markers of Atherosclerosis Course in Men With Stable Effort Angina].

  2016cites this paper
• Calcifications valvulaires chez l'hémodialysé au Maroc

  2016cites this paper
• Low Elastin Content of Carotid Plaques Is Associated with Increased Risk of Ipsilateral Stroke

  2015cites this paper
• Alternative Nf-kb Signaling in Atherogenesis

  2014cites this paper
• Suxiaojiuxin Pill Enhances Atherosclerotic Plaque Stability by Modulating the MMPs/TIMPs Balance in ApoE-deficient Mice

  2014cites this paper
• EFFECT OF PORTULACA OLERACEA SEEDS ON THE LEVELS OF MATRIX METALLOPROTEINASE 2, 9 AND TISSUE INHIBITOR MATRIX METALLOPROTEINASE 1 IN PATIENTS WITH TYPE 2 DIABETES

  2013cites this paper
• Matrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: Linkage-based approaches.

  2013cites this paper
• Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.

  2013cites this paper
• Pravastatin inhibits plaque rupture and subsequent thrombus formation in atherosclerotic rabbits with hyperlipidemia.

  2013cites this paper
• Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase functional polymorphisms.

  2011cites this paper
• Matrix metalloproteinases.

  2010cites this paper
• Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques.

  2010cites this paper
• Matrix metalloproteinases in atherothrombosis.

  2010cites this paper
• MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study.

  2010cites this paper
• Vascular Calcification and Cardiovascular Outcome in Dialysis Patients: The Role of Gene Polymorphisms

  2010cites this paper
• Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.

  2010cites this paper
• Changes in plasma levels of MMP-9, MMP-7 and their inhibitors in patients with coronary artery disease.

  2010cites this paper
• The impact of combined paraoxonase1 Q/R 192 and 5A6A matrix metalloproteinase-3 polymorphisms on coronary artery disease

  2010cites this paper
• Hydroxamic Acids: Biological Properties and Potential Uses as Therapeutic Agents

  2010cites this paper
• Genetic Variants and Atherosclerosis

  2009cites this paper
• A Role of Matrix Metalloproteinase-8 in Atherosclerosis

  2009cites this paper
• Matrix metalloproteinase-8 and the regulation of blood pressure, vascular inflammation, and atherosclerotic lesion growth.

  2009cites this paper
• Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.

  2009cites this paper
• Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.

  2008cites this paper
• Identification of Softness Syndrome-Associated Candidate Genes and DNA Sequence Variation in the Sea Squirt, Halocynthia roretzi

  2008cites this paper
• Progress in matrix metalloproteinase research.

  2008cites this paper
• Cysteine protease activity in the wall of abdominal aortic aneurysms.

  2007cites this paper
• Combined Effects of ACE and MMP-3 Polymorphisms On Migraine Development

  2007cites this paper
• Non-conventional genetic risk factors for cardiovascular disease.

  2006cites this paper
• Inflammation and matrix degrading proteases in coronary artery disease

  2006cites this paper
• Do metalloproteinases destabilize vulnerable atherosclerotic plaques?

  2006cites this paper
• Nonconventional genetic risk factors for cardiovascular disease

  2006cites this paper